RNAi for research and therapy.
Goldman
Michael A
MA
Department of Biology, San Francisco State University, San Francisco, CA 94132, USA. goldman@sfsu.edu
D000818:Animals; D000067696:Ataxin-1; D000067528:Ataxins; D001932:Brain Neoplasms / Q000188:drug therapy; D017173:Caenorhabditis elegans / Q000235:genetics / Q000254:growth & development; D003924:Diabetes Mellitus, Type 2 / Q000235:genetics / Q000378:metabolism; D066246:ErbB Receptors / Q000037:antagonists & inhibitors / Q000235:genetics; D005786:Gene Expression Regulation / Q000187:drug effects / Q000235:genetics; D018507:Gene Expression Regulation, Developmental / Q000187:drug effects / Q000235:genetics; D005801:Genes, Homeobox / Q000235:genetics; D006801:Humans; D007328:Insulin / Q000378:metabolism / Q000502:physiology; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000737:chemistry / Q000378:metabolism; D051379:Mice; D016688:Mice, Inbred NOD; D009419:Nerve Tissue Proteins / Q000235:genetics; D009687:Nuclear Proteins / Q000235:genetics; D034622:RNA Interference; D034741:RNA, Small Interfering / Q000235:genetics / Q000502:physiology / Q000627:therapeutic use; D012106:Research
C000593749:ATXN1 protein, human; D000067696:Ataxin-1; D000067528:Ataxins; C000593750:Atxn1 protein, mouse; D007328:Insulin; D009419:Nerve Tissue Proteins; D009687:Nuclear Proteins; D034741:RNA, Small Interfering; D066246:ErbB Receptors